![]() Argenx Argenx is a clinical-stage biotechnology company developing a pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. | ||
Founding Date | Founding Date 2008 | Founding Date 2016 |
Type | Type Public | Type Private |
Tags | ||
Locations | Locations Gent, BE HQ Minato City, JP Breda, NL Genève, CH Boston, US | Locations Gaithersburg, US HQ |
Employees | Employees 1,599 | Employees 15 |
Funding | ||
Total funding raised | Total funding raised $ 396.8m | Total funding raised $ 5.8m |

miRecule is a biotechnology company developing microRNA-based therapeutics.
View company